News
Sanofi-Dynavax: A Conservative Vaccine Deal With Upside Tail Risk (NASDAQ:SNY)
This article was written byFollowWith a background as a RN, I analyze healthcare-related stocks by evaluating clinical data, treatment guidelines,…
Editor's Top Picks
Worthington Enterprises: Upgrade To Buy On Improved Fundamentals (NYSE:WOR)
This article was written byFollowI focus on long-term investments while incorporating short-term shorts to uncover alpha opportunities. My investment approach…
Your one-stop resource for personal news and tips.
More form News
Bolloré SE: The Most Interesting Company In The World (BOIVF)
The following segment was excerpted from this fund letter. Bolloré (OTCPK:BOIVF): à 201 ans, l'entreprise…
Austria’s OMV and Abu Dhabi in talks over merging chemicals businesses
Receive free Chemicals updatesWe’ll send you a myFT Daily Digest email rounding up the latest…
Brighthouse Financial – Momentum Isn’t Slowing And Stock Looks Undervalued (NASDAQ:BHF)
Introduction It's not often you find a company trading at this low of a valuation…
Climate graphic of the week: Global warming is supercharging weather events, say scientists
Receive free Climate change updatesWe’ll send you a myFT Daily Digest email rounding up the…
QQQ And TQQQ: Risk-Reward Ratio Unfavourable Based On Historical Evidence (NASDAQ:QQQ)
In 2023, Invesco QQQ Trust ETF (NASDAQ:QQQ) exhibited extreme volatility, while triple-leveraged ProShares UltraPro QQQ…
Ukraine is currently doing Nato’s job for it
Receive free Nato updatesWe’ll send you a myFT Daily Digest email rounding up the latest…
U.S. IPO Weekly Recap: July IPO Market Kicks Off With Sizable Biotechs
Following the Independence Day lull, the July IPO market warmed up with two sizable biotechs,…
Goldman agrees to take edtech Kahoot private
Receive free Companies updatesWe’ll send you a myFT Daily Digest email rounding up the latest…
Highwoods Properties Stock: Up Since Trough, But Still A ‘Buy’ (NYSE:HIW)
Author's Notice: This article was first published on iREIT on Alpha in July 2023. Dear…
Music festivals are bad and it’s their fault
Receive free Life & Arts updatesWe’ll send you a myFT Daily Digest email rounding up…
Regeneron Pharmaceuticals: Overdependence On Eylea Brought To The Forefront (NASDAQ:REGN)
Introduction Regeneron Pharmaceuticals (NASDAQ:REGN) is a pioneering biotechnology company engaged in the invention, development, manufacturing,…
Tourists are back. Is it time to tell them to stay away?
Tourists grin for selfies in front of the gates of Auschwitz. They dive into the…
Medtronic: Expanding Product Portfolio Without Affecting Dividend Growth (NYSE:MDT)
Investment Outline Beating out their expectations for Q4 FY2023 as revenues reached $8.5 billion. The…
France attacks choice of prominent US economist for EU job
Receive free European Commission updatesWe’ll send you a myFT Daily Digest email rounding up the…
The Singing Machine Company, Inc. (MICS) Q4 2023 Earnings Call Transcript
The Singing Machine Company, Inc. (NASDAQ:MICS) Q4 2023 Earnings Conference Call July 14, 2023 5:30…